Scholar IQ
Try ScholarIQ free
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Rohto Pharmaceutical (Japan)

InstitutionResearch output, impact & collaborations

Rohto Pharmaceutical (Japan) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Rohto Pharmaceutical (Japan)?

ScholarIQrecord summary

Rohto Pharmaceutical (Japan) is a research organisation in Osaka, Japan. OpenAlex records 323 works and 11,388 citations for it. 1 researchers list it as their most recent affiliation.

How many works does Rohto Pharmaceutical (Japan) have?

ScholarIQindexed works

Rohto Pharmaceutical (Japan) has 323 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Rohto Pharmaceutical (Japan) have?

ScholarIQcitation count

Rohto Pharmaceutical (Japan) has 11,388 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Rohto Pharmaceutical (Japan)?

ScholarIQresearcher count

Rohto Pharmaceutical (Japan) has 1 researchers in the ScholarIQ index.

What is the average h-index at Rohto Pharmaceutical (Japan)?

ScholarIQavg h-index

Rohto Pharmaceutical (Japan) has an average h-index of 86 in OpenAlex.

What is the ROR of Rohto Pharmaceutical (Japan)?

ScholarIQror

The ROR for Rohto Pharmaceutical (Japan) is on the source record.

What is the OpenAlex record for Rohto Pharmaceutical (Japan)?

ScholarIQopenalex

The OpenAlex for Rohto Pharmaceutical (Japan) is on the source record.

Who are the most-cited researchers behind Rohto Pharmaceutical (Japan)?

ScholarIQtop researchers by citations
1
Tsutomu Imaizumi · Nitric Oxide and Endothelin Effects
612 works28,007 citations

What are the most-cited papers on Rohto Pharmaceutical (Japan)?

ScholarIQmost cited works
Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial
Eriko Tateishi-Yuyama, Hiroaki Matsubara, Toyoaki Murohara, Uichi Ikeda, Satoshi Shintani, Hiroya Masaki, Katsuya Amano, Yuji Kishimoto, Kohji Yoshimoto, Hidetoshi Akashi, Kazuyuki Shimada, Toshiji Iwasaka, Tsutomu Imaizumi
The Lancet. 20021,737 Citations
Mobilization of Endothelial Progenitor Cells in Patients With Acute Myocardial Infarction
Satoshi Shintani, Toyoaki Murohara, Hisao Ikeda, Takafumi Ueno, Tomoki Honma, Atsushi Katoh, Ken-ichiro Sasaki, Toshifumi Shimada, Yuichi Oike, Tsutomu Imaizumi
Circulation. 20011,186 CitationsOPEN ACCESS
Implantation of Bone Marrow Mononuclear Cells Into Ischemic Myocardium Enhances Collateral Perfusion and Regional Function via Side Supply of Angioblasts, Angiogenic Ligands, and Cytokines
Hiroshi Kamihata, Hiroaki Matsubara, Takashi Nishiue, Soichiro Fujiyama, Yoshiaki Tsutsumi, Ryozo Ozono, Hiroya Masaki, Yasukiyo Mori, Osamu Iba, Eriko Tateishi, Atsushi Kosaki, Satoshi Shintani, Toyoaki Murohara, Tsutomu Imaizumi, Toshiji Iwasaka
Circulation. 2001970 Citations
Transplanted cord blood–derived endothelial precursor cells augment postnatal neovascularization
Toyoaki Murohara, Hisao Ikeda, Junli Duan, Satoshi Shintani, Ken‐ichiro Sasaki, Hiroyuki Eguchi, Ichiro Onitsuka, Kazuo Matsui, Tsutomu Imaizumi
Journal of Clinical Investigation. 2000893 CitationsOPEN ACCESS
Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)—Chapter 2
Toshio Ogihara, Kenjiro Kikuchi, Hiroaki Matsuoka, Toshiro Fujita, Jitsuo Higaki, Masatsugu Horiuchi, Yutaka Imai, Tsutomu Imaizumi, Sadayoshi Ito, Hiroshi Iwao, Kazuomi Kario, Yuhei Kawano, Shokei Kim‐Mitsuyama, Genjiro Kimura, Hiroaki Matsubara, Hideo Matsuura, Mitsuhide Naruse, Ikuo Saito, Kazuyuki Shimada, Kazuaki Shimamoto, Hiromichi Suzuki, Shuichi Takishita, Norio Tanahashi, Takuya Tsuchihashi, Makoto Uchiyama, Shinichiro Ueda, Hirotsugu Ueshima, Satoshi Umemura, Toshihiko Ishimitsu, Hiromi Rakugi
Hypertension Research. 2009484 CitationsOPEN ACCESS

How much of the research on Rohto Pharmaceutical (Japan) is open access?

ScholarIQopen access share
67%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
0%
Bronze
67%
Closed
33%
470M+ articles · free account